Patent Opposition Database

Hide annotations

Related patent application (please put in national patent application/publication number or PCT application/publication number): 201737015848
Who filed: Balaji R
Country: India
Opposition type: Pre-Grant
Opposition status: Under Examination
Date: 04-12-2023
Patent type: Molecules

Click within the document, or manually enter the page number below

LOW COST STANDARD THERAPEUTICS opposition, TAF/FTC, (201817001590)

Countries: India Date: 2023
Sankalp Rehabilitation Trust opposition, Quabodepistat, (201737004817)

Countries: India Date: 2023
Thai Network of People Living with HIV/AIDS (TNP+) opposition, Lenacapavir, (WO/2014/134566)

Countries: Thailand Date: 2023
Thai Network of People Living with HIV/AIDS (TNP+) opposition, Baricitinib, (WO/2009/114512)

Countries: Thailand Date: 2023
Thai Network of People Living with HIV/AIDS (TNP+) opposition, Delamanid, (WO/2007/013477)

Countries: Thailand Date: 2023
Vietnam National Network of People Living with HIV/AIDS (VNP+) opposition, Nirmatrelvir and Ritonavir [PAXLOVID], (VN1-2021-07603 / WO/2021/250648)

Countries: Viet Nam Date: 2023
Fundación Grupo Efecto Positivo opposition, Tozinameran (BNT162b2) COVID-19 mRNA vaccine, (P20210101008 (AR121859A1))

Countries: Argentina Date: 2023
Initiative for Medicines, Access & Knowledge (I-Mak) opposition, lopinavir/ritonavir (LPV/r) , (339/MUMNP/2006)

Countries: India Date: 2007
Cipla Ltd. opposition, lopinavir/ritonavir (LPV/r) , (726/MUMNP/2009 (Divisional of 339/MUMNP/2006))

Countries: India Date: 2010
Matrix Laboratories Ltd. opposition, lopinavir/ritonavir (LPV/r) , (2474/DELNP/2009 (Divisional of 339/MUMNP/2006))

Countries: India Date: 2010

Balaji R Opposition, Elexacaftor, (201737015848)